microarray-based diagnostics

The Swedish molecular diagnostics firm will use the proceeds, in part, to fund the planned launch of its Immray PanCan-d assay for detecting pancreatic cancer.

This finding has the potential to expand the current utility of the panel to identify an important subgroup of people who would benefit from less treatment, the firm said. 

The technology uses Thermo Fisher Scientific microarrays to measure transcript levels in order to diagnose rejection of solid organ transplants.

The company plans to use Thermo Fisher Scientific's newly launched PharmacoScan array-based platform for its testing.

The firm also said it had a net loss of $7.9 million, or $3.50 per share, in 2014, compared to a net loss of $2.4 million, or $12.23 per share, in 2013.

The company said that its entire portfolio of microarray services in now manufactured under ISO 13485 certification.

Scientists have identified patterns of gene expression that can diagnose endometriosis, using machine learning to analyze transcriptome data obtained from microarray testing of uterine tissue.

Rebiotix will use Genetic Analysis' microarray-based GA-map dysbiosis test for use in its R&D programs for gastrointestinal diseases.

During a panel discussion at Cambridge Healthtech Institute's Advances in Prenatal Molecular Diagnostics conference in Boston earlier this month, representatives from four NIPT providers - Ariosa Diagnostics, Natera, Sequenom, and Illumina - shared their vision for their own tests and the future of NIPT.

NEW YORK (GenomeWeb) – Adarza BioSystems has closed the final tranche of a Series A round of financing that brought in a total of $6.8 million.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.